1 Innate Pharma Sa Receivables Turnover Ratio (IPHA), from the fourth quarter 2025 to the fourth quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Innate Pharma Sa  (NASDAQ: IPHA)
 

Innate Pharma Sa Accounts Receivables Turnover Ratio from the fourth quarter 2025 to the fourth quarter 2024

Quarterly Results, Trends, Rankings, Statistics


According to Innate Pharma Sa Balance Sheet, in the fourth quarter 2025, company has not reported any Accounts receivable.
See Innate Pharma Sa Balance Sheet

If we take a look into Healthcare sector 469 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 3261.

What is Receivable Turnover Ratio?
What is Innate Pharma Sa Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IPHA Receivables Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change -55.25 % - - - -67.36 %
Receivable Turnover Ratio (TTM) - - - - -
IPHA's Total Ranking # 3261 # 0 # # #
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 49
Healthcare Sector # 470
Overall Market # 3261

Receivable Turnover Ratio Statistics
High Average Low
0.33 0.21 0.09
(Dec 31 2023)   (Dec 31 2021)





IPHA Company Profile • Back to IPHA Efficiency Comparisons • Compare IPHA Receivables Turnover Ratio to its Competitors

Financial Statements
Innate Pharma Sa's Accounts Receivable $ 0 Millions Visit IPHA's Balance sheet
Innate Pharma Sa's Sales TTM $ 10 Millions Visit IPHA's Income Statement
Sources of IPHA's Revenues Visit IPHA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IPHA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IPHA's Growth Rates IPHA's Roa IPHA's Inventory Turnover Ratio IPHA's Dividend Comparisons
IPHA's Profitability Ratios IPHA's Roi IPHA's Asset Turnover Ratio IPHA's Dividend Growth
IPHA's Valuation Ratios IPHA's Roe IPHA's Financial Strength Ratios IPHA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Receivable at quarter ending Dec 31 2025

Date modified: 2026-07-07T11:39:32+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.